Pharmacyte Biotech Inc Stock (PMCB) Forecast
The Pharmacyte Biotech Inc (PMCB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.15, representing a -59.13% decrease from the current price of $0.367. The highest analyst price target is $0.2957, and the lowest is $0.00427.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PMCB Price Target
Average 0.3882 (+5.77% Downside)
Is Pharmacyte Biotech Inc (PMCB) A Buy Now?
Oscillators
Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral
Moving Averages
Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell
According to our latest analysis, PMCB could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PMCB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.61 indicates that PMCB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.29 indicates that PMCB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 86.13 indicates that PMCB is overbought. This suggests that PMCB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 20.12 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of 47.70 indicates that PMCB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PMCB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharmacyte Biotech Inc financial reports and earnings history, Pharmacyte Biotech Inc (PMCB) stock could reach $1.24 by 2030, $2.71 by 2040 and $8.93 by 2050. See the projected annual prices until 2050 of the Pharmacyte Biotech Inc stock below:
- Pharmacyte Biotech Inc (PMCB) is expected to reach an average price of $0.6422 in 2035, with a high prediction of $0.8313 and a low estimate of $0.4852. This indicates an +74.96% change from the last recorded price of $0.367.
- Pharmacyte Biotech Inc (PMCB) stock is projected to chart a bullish course in 2040, with an average price target of $2.05, representing an +458.39% change from its current level. The forecast ranges from a conservative $1.91 to a sky-high $2.71.
- Our analysts predict Pharmacyte Biotech Inc (PMCB) to change +1,106% by 2045, soaring from $4.01 to an average price of $4.43, potentially reaching $4.99. While $4.01 is the low estimate, the potential upside is significant.
- Pharmacyte Biotech Inc (PMCB) stock is expected to climb by 2050, reaching an average of $6.42, a +1,650% change from its current level. However, a wide range of estimates exists, with high and low targets of $8.93 and $6.50, respectively, highlighting the market's uncertainty.
Pharmacyte Biotech Inc Stock (PMCB) Year by Year Forecast
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2026
The predicted value for Pharmacyte Biotech Inc (PMCB) in 2026 is set at an average of $0.5611. Estimates vary from a peak of $1.05 to a trough of $0.00427, indicating an +52.87% surge from the present price of $0.367.
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharmacyte Biotech Inc (PMCB) is $0.3246, with a high forecast of $0.9716 and a low forecast of $0.0239. This indicates an -11.56% decrease from the last price of $0.367.
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2028
In 2028, Pharmacyte Biotech Inc (PMCB) is projected to reach an average price of $1.02, with a high projection of $1.45 and a low estimate of $0.6103. This indicates an +179.24% rise from the last price of $0.367.
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2029
The 2029 price forecast for Pharmacyte Biotech Inc Stock (PMCB) is $0.6586 on average, with a high prediction of $1.15 and a low estimate of $0.3153. This represents an +79.42% increase from the previous price of $0.367.
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2030
Pharmacyte Biotech Inc Stock (PMCB) is expected to reach an average price of $0.4466 in 2030, with a high forecast of $1.24 and a low forecast of $0.0405. This signifies an +21.67% surge from the last price of $0.367.
